All Stories

  1. Untreated perinatal paternal depression: Effects on offspring
  2. In children 7 years of age, prenatal antidepressant exposure is not associated with increased risk of poor behavioural outcomes after adjusting for maternal factors including antenatal mood
  3. Untreated depression during pregnancy: Short- and long-term effects in offspring. A systematic review
  4. Safety concerns associated with second-generation antipsychotic long-acting injection treatment. A systematic update
  5. Neurodevelopmental outcomes in infants exposed in utero to antipsychotics: a systematic review of published data
  6. Placental and fetal effects of antenatal exposure to antidepressants or untreated maternal depression
  7. Pharmacological Management of Borderline Personality Disorder in a Pregnant Woman with a Previous History of Alcohol Addiction: A Case Report
  8. Prenatal antidepressant exposure and the risk of autism spectrum disorders in children. Are we looking at the fall of Gods?
  9. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms
  10. Managing antidepressant treatment in pregnancy and puerperium. Careful with that axe, Eugene
  11. Systematic review of management for treatment-resistant depression in adolescents
  12. Pregnancy exposure to second-generation antipsychotics and the risk of gestational diabetes
  13. A safety evaluation of aripiprazole for treating schizophrenia during pregnancy and puerperium
  14. Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions
  15. Tricyclic antidepressants in pregnancy and puerperium
  16. Anxiety and Sleep Disorders, Psychopharmacology, and Pregnancy
  17. Adverse Effects Associated with Second‐Generation Antipsychotic Long‐Acting Injection Treatment: A Comprehensive Systematic Review
  18. Bipolar disorder in pregnancy: to treat or not to treat?
  19. Further Findings Linking SSRIs During Pregnancy and Persistent Pulmonary Hypertension of the Newborn
  20. Lithium in pregnancy: the need to treat, the duty to ensure safety
  21. Clinical Usefulness of Second-Generation Antipsychotics in Treating Children and Adolescents Diagnosed with Bipolar or Schizophrenic Disorders
  22. Efficacy of Antidepressant Medications in Children and Adolescents With Obsessive-Compulsive Disorder
  23. Aripiprazole and Pregnancy
  24. Suicidal mothers
  25. Neonatal Withdrawal Reactions Following Late in Utero Exposure to Antidepressant Medications
  26. Editorial [Hot Topic: Psychotropic Drugs in Pregnancy and Breastfeeding: Weighing the Iatrogenic Risks for the Mother-Infant Pair with the Risks Associated with an Untreated Maternal Disorder (Guest Editor: Salvatore Gentile)]
  27. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects
  28. Drug treatment for mood disorders in pregnancy
  29. Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: A systematic review
  30. Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials
  31. Neurodevelopmental effects of prenatal exposure to psychotropic medications
  32. On Categorizing Gestational, Birth, and Neonatal Complications Following Late Pregnancy Exposure to Antidepressants: The Prenatal Antidepressant Exposure Syndrome
  33. Antidepressant Use in Children and Adolescents Diagnosed with Major Depressive Disorder: What Can We Learn from Published Data?
  34. Contributing factors to weight gain during long-term treatment with second-generation antipsychotics. A systematic appraisal and clinical implications
  35. Selective Serotonin Reuptake Inhibitor Exposure During Early Pregnancy and the Risk of Fetal Major Malformations
  36. A systematic review of quality of life and weight gain-related issues in patients treated for severe and persistent mental disorders: focus on aripiprazole
  37. Prolonged exposure to SRIs during pregnancy increases risks of adverse neonatal outcomes
  38. Topiramate in Pregnancy and Breastfeeding
  39. Pregnancy Exposure to Serotonin Reuptake Inhibitors and the Risk of Spontaneous Abortions
  40. Antipsychotic Therapy During Early and Late Pregnancy. A Systematic Review
  41. Managing the Suicidal Risk in Pregnant Women with Severe and Persistent Psychiatric Disorder: Focus on Antisuicidal Drugs and Somatic Interventions
  42. Infant Safety With Antipsychotic Therapy in Breast-Feeding
  43. Psychotropic drugs in pregnancy and lactation. Clinical aspects
  44. Use of Escitalopram during Pregnancy
  45. E.06.02 SSRI's and mood stabilizers in pregnancy and during breastfeeding – clinical aspects
  46. P.2.c.001 SSRIs in pregnancy; what happens with the mother?
  47. Consecutive exposure to lamotrigine and citalopram during pregnancy
  48. Erratum: Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review
  49. Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review
  50. SSRIs during breastfeeding: spotlight on milk-to-plasma ratio
  51. The Author??s Reply
  52. Serotonin Reuptake Inhibitor-Induced Perinatal Complications
  53. Atypical Antipsychotics for the Treatment of Bipolar Disorder
  54. Use of Contemporary Antidepressants during Breastfeeding
  55. Nontricyclic Antidepressants
  56. Escitalopram Late in Pregnancy and While Breast-Feeding
  57. Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers
  58. Quetiapine–fluvoxamine combination during pregnancy and while breastfeeding
  59. The Author???s Reply
  60. Long-Term Treatment with Atypical Antipsychotics and the Risk of Weight Gain
  61. The Role of Estrogen Therapy in Postpartum Psychiatric Disorders: An Update
  62. Lamotrigine in pregnancy and lactation
  63. More than half the women with a history of psychosis have a psychiatric episode in the first year after childbirth
  64. The Safety of Newer Antidepressants in Pregnancy and Breastfeeding
  65. SSRIs in Pregnancy and Lactation
  66. P.6.089 The safety of new mood stazers inpregnancy and lactation
  67. Clinical Utilization of Atypical Antipsychotics in Pregnancy and Lactation
  68. Antipsychotic-associated weight gain
  69. The forgotten therapy: Depot neuroleptics in the era of atypical antipsychotics, a community based study
  70. Oxcarbazepine in Pregnancy and Lactation
  71. Mood disorders in patients with chronic simple glaucoma
  72. A review of the literature on antidepressant use during pregnancy